Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Nuwellis, Inc. (NUWE)

Nuwellis posts updated investor presentation citing 20% first-half 2026 revenue growth

Positive Impact 2 of 5 other Written later

Nuwellis furnished an updated corporate presentation dated August 25, 2026, under Regulation FD, for use in investor communications and conferences. The deck highlights 20% first-half 2026 revenue growth and a second-quarter 2026 gross margin of 76%, compared with 56% in the prior-year period, and says cash runway extends through the second quarter of 2027.

Key points

  • First-half 2026 revenue grew 20% over the prior-year period, per the presentation.
  • Second-quarter 2026 gross margin was 76%, versus 56% in the prior-year period.
  • The company says cash runway runs through the second quarter of 2027.
  • Company anticipates an FDA submission for the Aquadex pediatric label expansion by year-end 2026.

The filing

CompanyNuwellis, Inc. (NUWE)
Form8-K, current report
Filed with the SECAug 25, 2026, 9:26 PM ET
Accession number0001140361-26-034367

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 25, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.